Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Attaei, Marjan; Khatib, Rasha; McKee, Martin; Lear, Scott; Dagenais, Gilles; Igumbor, Ehimario; AlHabib, Khalid; Kaur, Manmeet; Kruger, Lanthe; Teo, Koon; Lanas, Fernando; Yusoff, Khalid; OĞUZ, AYTEKİN; Gupta, Rajeev; Yusufali, Afzalhussein; Bahonar, Ahmad; Kutty, Raman; Rosengren, Annika; Mohan, Viswanathan; Avezum, Alvaro; Yusuf, Rita; Szuba, Andrzej; Rangarajan, Sumathy; Chow, Clara; Yusuf, HASAN

doi:10.1016/s2468-2667(17)30141-x

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Copy For Citation

Attaei M. W., Khatib R., McKee M., Lear S., Dagenais G., Igumbor E. U., ...More

LANCET PUBLIC HEALTH, vol.2, no.9, 2017 (SCI-Expanded)

Publication Type: Article / Article
Volume: 2 Issue: 9
Publication Date: 2017
Doi Number: 10.1016/s2468-2667(17)30141-x
Journal Name: LANCET PUBLIC HEALTH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Ankara University Affiliated: Yes

Abstract

Background Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development.